The pharmaceuticals sector received FDI of ₹4,975 crore in 2015-16, down from ₹9,052 crore in 2014-15, the Parliament was informed on Tuesday. India’s FDI policy provides for 100% FDI under automatic route in greenfield pharma (involves start of new venture with construction of new facilities) and upto 100% under government route in brownfield pharma (involves purchase of existing facilities).